Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01912599 · ClinicalTrials.gov registry record · NA
Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma
A NA study of Normal-Tension Glaucoma, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT01912599 is a NA study of Normal-Tension Glaucoma that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01912599, a NA study of Normal-Tension Glaucoma, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: To study the feasibility of a larger study by determining the tolerability of measuring blood pressure (BP) and intraocular pressure (IOP) over 24 hours in an ambulatory fashion with automatic devices. Participants: 20 patients with moderate to severe normal tension glaucoma and 20 non-glaucomatous patients. Procedures (methods): Both BP and IOP will be measured automatically in each participant in an ambulatory fashion during a 24-hour period. BP will be monitored using an appropriately sized cuff Oscar 2 (Suntech Medical, Morrisville, NC), which will be placed by a person trained in ambulatory BP monitoring devices. The device will be set up to automatically inflate every 30 minutes during the day and every hour during the night to measure and record the BP. IOP will be measured using Sensimed Triggerfish contact lens (Sensimed AG, Lausanne, Switzerland); the measurements will be taken and recorded every 10 minutes. The contact lens will be inserted by eye doctors (investigators). Both monitoring devices will be removed the following day.
Conditions Studied
Interventions
- DEVICE Sensimed Triggerfish
- DEVICE Blood Pressure
Study Locations (1)
North Carolina
- UNC Kittner Eye Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01912599
The ClinicalTrials.gov registry entry for NCT01912599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Normal-Tension Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Sensimed Triggerfish is the first listed.
NCT01912599 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01912599 about?
NCT01912599 is a clinical study titled "Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma". Purpose: To study the feasibility of a larger study by determining the tolerability of measuring blood pressure (BP) and intraocular pressure (IOP) over 24 hours in an ambulatory fashion with automatic devices. Participants: 20 patients with moderate to severe normal tension glaucoma and 20 non-gla...
What is the current status of trial NCT01912599?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2013-07. Estimated completion is 2014-07.
What conditions does trial NCT01912599 study?
This clinical trial studies the following conditions: Normal-Tension Glaucoma.
What interventions are being tested in trial NCT01912599?
The interventions under investigation include: Sensimed Triggerfish (DEVICE), Blood Pressure (DEVICE).
Who is sponsoring clinical trial NCT01912599?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01912599 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.